224 related articles for article (PubMed ID: 25958831)
1. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
3. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord.
Chera BS; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1380-5. PubMed ID: 19942356
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.
Mohamed ASR; Smith BD; Smith JB; Sevak P; Malek JS; Kanwar A; Browne T; Gunn GB; Garden AS; Frank SJ; Morrison WH; Phan J; Zafereo M; Skinner H; Lai SY; Hutcheson KA; Lewin JS; Hessel AE; Thekdi AA; Weber RS; Fuller CD; Rosenthal DI
Laryngoscope; 2020 Jan; 130(1):146-153. PubMed ID: 30756394
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
Samuels MA; Freedman LM; Elsayyad N
Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
[TBL] [Abstract][Full Text] [Related]
6. Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
Razavian NB; D'Agostino RB; Shenker RF; Hughes RT
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):652-663. PubMed ID: 37150263
[TBL] [Abstract][Full Text] [Related]
7. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer.
Atalar B; Gungor G; Caglar H; Aydin G; Yapici B; Ozyar E
Tumori; 2012; 98(3):331-6. PubMed ID: 22825509
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for early-stage glottic cancer.
Berwouts D; Swimberghe M; Duprez F; Boterberg T; Bonte K; Deron P; De Gersem W; De Neve W; Madani I
Head Neck; 2016 Apr; 38 Suppl 1():E179-84. PubMed ID: 25537856
[TBL] [Abstract][Full Text] [Related]
10. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
Sert F; Karakoyun-Çelik O; Esassolak MA
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
[TBL] [Abstract][Full Text] [Related]
11. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
Rosenthal DI; Fuller CD; Barker JL; Mason B; Garcia JA; Lewin JS; Holsinger FC; Stasney CR; Frank SJ; Schwartz DL; Morrison WH; Garden AS; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):455-61. PubMed ID: 19679406
[TBL] [Abstract][Full Text] [Related]
12. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
13. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
15. Surviving hypopharynx-larynx carcinoma in the era of IMRT.
Studer G; Peponi E; Kloeck S; Dossenbach T; Huber G; Glanzmann C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1391-6. PubMed ID: 20056352
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
17. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
Bicakci BC; Mustafayev TZ; Cetinayak O; Igdem S; Birgi SD; Meydan D; Demircioglu F; Atalar B; Ozyar E; Akman F
Head Neck; 2022 Aug; 44(8):1825-1832. PubMed ID: 35596585
[TBL] [Abstract][Full Text] [Related]
19. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dosimetric implications of intensity-modulated radiotherapy for early-stage glottic carcinoma.
Ward MC; Pham YD; Kotecha R; Zakem SJ; Murray E; Greskovich JF
Med Dosim; 2016; 41(1):64-9. PubMed ID: 26553472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
